Chad Heatwole
| Title | Assistant Professor |
|---|
| Institution | School of Medicine and Dentistry |
|---|
| Department | Neurology |
|---|
| Address | University of Rochester Medical Center School of Medicine and Dentistry 601 Elmwood Ave, Box 673 Rochester NY 14642
|
|---|
|
|
|
|
|
|
| Student Elective Term Scholarship Winner (MMA) 1999 | |
|
|
| Awarded Virginia Tech's Best ESM Ind. Senior Project Presentation 1997 | Virginia Tech | |
|
|
| Tau Beta Pi National Engineering Honor Society | |
|
|
| Golden Key Member | |
|
|
| Dean's List (General Engineering, and in ESM) | |
|
|
| Board of Supervisors Academic Excellence Award | |
|
|
| American Neurology Association Scholarship Winner 2004 | |
|
|
| Tau Beta Pi National Engineering Honor Society | |
|
|
| Golden Key Member | |
|
|
| Dean's List (General Engineering, and in ESM) | |
|
|
| Board of Supervisors Academic Excellence Award | |
|
|
| Patient and Family-Centered Care award (2011) | |
|
|
| Patient and Family Centered Care Award | University of Rochester | |
|
|
| Strong Star Award for Exceptional Service and Displaying Compassion and Respect to Patients, Familes and Co-workers | | 1997 |
|
| Awarded Virginia Tech's Best ESM 1997 Ind. Senior Project Presentation | | 1998 |
-
| 1999 | S.O.M. State Discretionary Scholarship Winner | | 1998 |
-
| 1999 | S.O.M. State Discretionary Scholarship Winner 1998, 1999 | | 1999 |
|
| Student Elective Term Scholarship Winner (MMA) 1999 | | 2003 |
|
| UCB Pharma, Inc. Neurology Resident Scholar | | 2003 |
|
| UCB Pharma, Inc. Neurology Resident Scholar. 2003 | | 2004 |
|
| American Neurology Association Scholarship Winner, Toronto 2004 | American Neurology Association | | 2005 |
|
| Ad Hoc editor for Neurology | | 2006 |
-
| 2008 | NIH Clinical Research Loan Repayment Grant Recipient | NIH | | 2006 |
-
| 2007 | NIH Experimental Therapeutics Grant Recipient for | NIH | | 2007 |
|
| NIH Clinical and Translational Science Institute K12 Award Recipient | NIH | | 2008 |
-
| 2010 | NIH Clinical Research Loan Repayment Grant Recipient | NIH | | 2008 |
|
| Clinical Research Loan Repayment Grant Renewal Recipient | NIH | | 2008 |
|
| Paul Wellstone Muscular Dystrophy Cooperative Research Center Umbrella Center | MDCRC | | 2008 |
-
| 2011 | 2008 Muscular Dystrophy Association Translational Research Infrastructure Grant Award Winner (Funding from 2008-2011) | | 2008 |
-
| 2010 | ECRIP (Empire Clinical Research Investigator Program) Grant Award Winner ( | | 2008 |
-
| 2013 | NIH K23 Career Development Grant Award Winner (NIAMS) | NIH | | 2010 |
|
| Clinical Research Loan Repayment Grant Renewal Recipient | NIH | | 2010 |
-
| 2012 | NIH Clinical Research Loan REpayment Grant REnewal Recipient | NIH | | 2011 |
-
| 2015 | FDA Research Grant: Mexiletine Treatment in Myotonic Dystrophy Type-1 (Co-Investigator) | FDA | | 2012 |
-
| 2014 | Myotonic Dystrophy Foundation Research Grant (Supervising Mentor for Dr. Nick Johnson) | Myotonic Dystrophy Foundation |
Chad Heatwole, MD, MS-CI is a neuromuscular clinician and researcher from the University of Rochester. He has an engineering degree from Virginia Tech, a medical degree from the Medical College of Virginia, a master's degree in clinical investigation, and has completed a University of Rochester neurology residency, electrophysiology fellowship, and NIH-funded neuromuscular experimental therapeutics fellowship. His research funding has included a National Institute of Arthritis and Musculoskeletal and Skin Diseases K23 award, a Muscular Dystrophy Association TRIG award, and a New York State ECRIP award (among other awards). Dr. Heatwole's research has led to the development of an international network dedicated to improving the quality-of-life of neuromuscular patients through patient-centered clinical research. His primary professional interests include providing optimal care to patients with neuromuscular disorders, performing electrodiagnostic studies, training medical personnel, evaluating novel experimental therapeutics for neurological diseases though clinical trials, and developing an improved infrastructure to utilize disease-specific, patient-relevant endpoint measures for use in clinical trials and patient monitoring.
-
Johnson NE, Quinn C, Eastwood E, Tawil R, Heatwole CR. Patient-identified disease burden in facioscapulohumeral muscular dystrophy. Muscle Nerve. 2012 Dec; 46(6):948-50.
-
Johnson NE, Heatwole CR. Myotonic dystrophy: from bench to bedside. Semin Neurol. 2012 Jul; 32(3):246-54.
-
Heatwole C, Bode R, Johnson N, Quinn C, Martens W, McDermott MP, Rothrock N, Thornton C, Vickrey B, Victorson D, Moxley R. Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1). Neurology. 2012 Jul 24; 79(4):348-57.
-
Heatwole C, Johnson N, Holloway R, Noyes K. Plasma Exchange versus Intravenous Immunoglobulin for Myasthenia Gravis Crisis: An Acute Hospital Cost Comparison Study. J Clin Neuromuscul Dis. 2011 Dec; 13(2):85-94.
-
Heatwole C, Johnson N, Goldberg B, Martens W, Moxley R. Laboratory abnormalities in patients with myotonic dystrophy type 2. Arch Neurol. 2011 Sep; 68(9):1180-4.
-
Heatwole CR, Eichinger KJ, Friedman DI, Hilbert JE, Jackson CE, Logigian EL, Martens WB, McDermott MP, Pandya SK, Quinn C, Smirnow AM, Thornton CA, Moxley RT. Open-label trial of recombinant human insulin-like growth factor 1/recombinant human insulin-like growth factor binding protein 3 in myotonic dystrophy type 1. Arch Neurol. 2011 Jan; 68(1):37-44.
-
Logigian EL, Twydell P, Dilek N, Martens WB, Quinn C, Wiegner AW, Heatwole CR, Thornton CA, Moxley RT. Evoked myotonia can be "dialed-up" by increasing stimulus train length in myotonic dystrophy type 1. Muscle Nerve. 2010 Feb; 41(2):191-6.
-
Heatwole C, Ciafaloni E. Mycophenolate mofetil for myasthenia gravis: a clear and present controversy. Neuropsychiatr Dis Treat. 2008 Dec; 4(6):1203-9.
-
Heatwole C. International Education Issues: practicing and teaching international neurology: the Krakow experience. Neurology. 2007 Oct 23; 69(17):1721-3.
-
Heatwole CR, Moxley RT. The nondystrophic myotonias. Neurotherapeutics. 2007 Apr; 4(2):238-51.
-
Heatwole CR, Miller J, Martens B, Moxley RT. Laboratory abnormalities in ambulatory patients with myotonic dystrophy type 1. Arch Neurol. 2006 Aug; 63(8):1149-53.
-
Heatwole CR, Berg MJ, Henry JC, Hallman JL. Extreme spindles: a distinctive EEG pattern in Mycoplasma pneumoniae encephalitis. Neurology. 2005 Mar 22; 64(6):1096-7.
|
Heatwole's Networks
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|